Current and emerging treatment options for vernal keratoconjunctivitis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Expert Opinion on Orphan Drugs

• Publication date

  2017-03-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/21678707.2017.1300524
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Vernal Keratoconjunctivitis on School Children in Egypt

  2017cited by this paper
• Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management

  2016influential reference
• Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.

  2016cited by this paper
• Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis

  2016cited by this paper
• Steroid-Sparing Effect of 0.1% Tacrolimus Eye Drop for Treatment of Shield Ulcer and Corneal Epitheliopathy in Refractory Allergic Ocular Diseases.

  2016cited by this paper
• Quiescent and Active Tear Protein Profiles to Predict Vernal Keratoconjunctivitis Reactivation

  2016cited by this paper
• Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm

  2016cited by this paper
• Prevalence and associated factors of vernal keratoconjunctivitis among children in Gondar city, Northwest Ethiopia

  2016cited by this paper
• Omalizumab Treatment of Vernal Keratoconjunctivitis.

  2016cited by this paper
• Sex Hormones in Allergic Conjunctivitis: Altered Levels of Circulating Androgens and Estrogens in Children and Adolescents with Vernal Keratoconjunctivitis

  2015cited by this paper
• Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine‐resistant vernal keratoconjunctivitis: A randomized, comparative, double‐blind, crossover study

  2015cited by this paper
• Assessment of Corneal Alterations by Confocal Microscopy in Vernal Keratoconjunctivitis

  2015cited by this paper
• Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors

  2015cited by this paper
• Topical Tacrolimus 0.03% as Sole Therapy in Vernal Keratoconjunctivitis: A Randomized Double-Masked Study

  2014cited by this paper
• An essential role for dendritic cells in vernal keratoconjunctivitis: analysis by laser scanning confocal microscopy

  2014cited by this paper
• A Double Blind Clinical Trial on the Efficacy of Honey Drop in Vernal Keratoconjunctivitis

  2014cited by this paper
• Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement

  2014cited by this paper
• Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial.

  2014cited by this paper
• Current status of therapy with omalizumab in children

  2014cited by this paper
• Severe vernal keratoconjunctivitis successfully treated with subcutaneous omalizumab.

  2013cited by this paper
• Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India

  2013cited by this paper
• Management, clinical outcomes, and complications of shield ulcers in vernal keratoconjunctivitis.

  2013influential reference
• Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis.

  2013cited by this paper
• The Efficacy of Topical Interferon Alpha 2b Treatment in Refractory Vernal Keratoconjunctivitis

  2012cited by this paper
• A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.

  2012cited by this paper
• Systemic Atopy and Immunoglobulin Deficiency in Turkish Patients with Vernal Keratoconjunctivitis

  2012cited by this paper
• Vernal keratoconjunctivitis: an update

  2012influential reference
• Omalizumab. An option in vernal keratoconjunctivitis?

  2012cited by this paper
• Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety

  2012cited by this paper
• Surgical Debridement Plus Topical Cyclosporine a in the Treatment and Vernal Shield Ulcers

  2012cited by this paper
• Corneal confocal microscopy in patients with vernal keratoconjunctivitis.

  2012cited by this paper
• Subcutaneous Allergen-specific Immunotherapy Versus Topical Treatment in Vernal Keratoconjunctivitis

  2012cited by this paper
• Vernal Keratoconjunctivitis With Limbal Stem Cell Deficiency

  2011cited by this paper
• Toll-like receptors in ocular surface diseases: overview and new findings.

  2011cited by this paper
• Vernal keratoconjunctivitis in school children in Rwanda and its association with socio-economic status: a population-based survey.

  2011cited by this paper
• Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study.

  2011cited by this paper
• Transforming growth factor‐β/Smad ‐ signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis

  2011cited by this paper
• Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial

  2011cited by this paper
• Acidic Mammalian Chitinase and the Eye: Implications for Ocular Inflammatory Diseases

  2011cited by this paper
• Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis

  2011cited by this paper
• A clinical study to assess the efficacy of Triyushnadi Anjana in Kaphaja Abhishyanda with special reference to vernal keratoconjunctivitis

  2010cited by this paper
• Long-Term Safety and Efficacy of Topical Cyclosporine in 156 Children with Vernal Keratoconjunctivitis

  2010cited by this paper
• Tailored approach to the treatment of vernal keratoconjunctivitis.

  2010cited by this paper
• A Randomized, Placebo-Controlled Clinical Trial of Tacrolimus Ophthalmic Suspension 0.1% in Severe Allergic Conjunctivitis

  2010cited by this paper
• In vivo laser scanning confocal microscopy of vernal keratoconjunctivitis

  2010cited by this paper
• Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients

  2009cited by this paper
• A Large Prospective Observational Study of Novel Cyclosporine 0.1% Aqueous Ophthalmic Solution in the Treatment of Severe Allergic Conjunctivitis

  2009cited by this paper
• Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis

  2008cited by this paper
• Ocular allergy treatment.

  2008cited by this paper
• Prevalence of vernal keratoconjunctivitis: a rare disease?

  2008cited by this paper
• Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.

  2008cited by this paper
• Clinical grading of vernal keratoconjunctivitis

  2007cited by this paper
• Nerve growth factor has a modulatory role on human primary fibroblast cultures derived from vernal keratoconjunctivitis-affected conjunctiva

  2007cited by this paper
• Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire.

  2007cited by this paper
• Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis

  2007cited by this paper
• Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients

  2007cited by this paper
• Topical Bromfenac Sodium for Long-Term Management of Vernal Keratoconjunctivitis

  2007cited by this paper
• Natural killer cells in vernal keratoconjunctivitis.

  2007cited by this paper
• Comparação entre o uso tópico do fumarato de cetotifeno 0,025% e do cloridrato de olopatadina 0,1% no tratamento da ceratoconjuntivite primaveril

  2006cited by this paper
• Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis

  2006cited by this paper
• Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study.

  2006cited by this paper
• [Comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis].

  2006cited by this paper
• Immunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitis

  2006cited by this paper
• Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood

  2006cited by this paper
• Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.

  2006cited by this paper
• Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis.

  2006cited by this paper
• Expression of Toll-like receptors in healthy and allergic conjunctiva.

  2005cited by this paper
• Surgical Management of Corneal Plaques in Vernal Keratoconjunctivitis: A Clinicopathologic Study

  2004cited by this paper
• Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.

  2003cited by this paper
• Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma.

  2003cited by this paper
• Role of Chemokines in Vernal Keratoconjunctivitis

  2003cited by this paper
• Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.

  2002cited by this paper
• Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis.

  2002cited by this paper
• Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies.

  2001cited by this paper
• Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs.

  2001influential reference
• Amniotic membrane transplantation in the management of shield ulcers of vernal keratoconjunctivitis.

  2001cited by this paper
• Topical cyclosporin A in the management of vernal keratoconjunctivitis

  2001cited by this paper
• Comparison of Lodoxamide 0.1% Ophthalmic Solution and Levocabastine 0.05% Ophthalmic Suspension in Vernal Keratoconjunctivitis

  2001cited by this paper
• Tear tryptase in vernal keratoconjunctivitis.

  2001cited by this paper
• Allergic and immunologic disorders of the eye. Part I: immunology of the eye.

  2000cited by this paper
• Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.

  2000cited by this paper
• Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup.

  2000cited by this paper
• Combined medical and surgical treatment of severe vernal keratoconjunctivitis.

  2000cited by this paper
• Ocular complications of vernal keratoconjunctivitis.

  1999influential reference
• Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long‐term management of vernal keratoconjunctivitis

  1999cited by this paper
• Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis.

  1999cited by this paper
• Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry.

  1999cited by this paper
• The eosinophil and the eye

  1997cited by this paper
• Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.

  1997cited by this paper
• Adhesion molecules in vernal keratoconjunctivitis

  1997cited by this paper
• Human conjunctival mast cell responses in vitro to various secretagogues.

  1996cited by this paper
• Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis

  1995cited by this paper
• Estrogen and progesterone receptors in vernal keratoconjunctivitis.

  1995cited by this paper
• Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis.

  1995influential reference
• Histamine and Tryptase Levels in Allergic Conjunctivitis and Vernal Keratoconjunctivitis

  1994cited by this paper
• Topical cyclosporine in vernal keratoconjunctivitis.

  1991cited by this paper
• Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis.

  1990cited by this paper
• Perennial allergic conjunctivitis: definition, clinical characteristics and prevalence. A comparison with seasonal allergic conjunctivitis.

  1986cited by this paper
• Vernal keratopathy and its management.

  1981influential reference
• Vernal keratopathy and its management.

  1981cited by this paper

• Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape.

  2023cites this paper
• Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus

  2021cites this paper
• Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms

  2021cites this paper
• The Efficacy of 0.03% Dermatological Tacrolimus Ointment for Refractory Vernal Keratoconjunctivitis.

  2020cites this paper
• Eye drop emulsion containing 0.1% cyclosporin (1 mg/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy

  2019cites this paper
• OPTH_A_181811 1147..1155

  2019cites this paper